CJC-1295 research guide for Kānkon. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
For anyone in Kānkon searching for CJC-1295, the first thing to know is that this compound is available only through an online research supply market. What this means for Kānkon researchers is that your location matters far less than your ability to assess COA data — and those verification methods are accessible to anyone. A properly operating CJC-1295 supplier's COA should include HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all corresponding to the vial you receive. The sections below cover what Kānkon researchers need to know about finding, evaluating, and storing CJC-1295 for legitimate research applications.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Kānkon comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source CJC-1295 — Vendor Guide
The most consistent path to quality CJC-1295 is starting with community forums — peptide forums maintain informal vendor reputation databases that are more reliable than search results. A COA for CJC-1295 should include: HPLC purity percentage with the underlying chromatogram, mass spectrometry data confirming the correct molecular weight, endotoxin test results, and a residual solvent panel — all batch-matched. For Kānkon researchers evaluating unfamiliar vendors: a modest first purchase to test the product before placing larger orders is the accepted approach among experienced researchers. For Kānkon researchers making a first CJC-1295 purchase: apply these quality criteria before ordering, start with a modest quantity, and confirm the COA batch number matches your received product before use.
Order CJC-1295 — ships to Kānkon
COA-verified · International tracking · Research grade
All use of CJC-1295 in Kānkon or anywhere must be research use only — this compound is not approved for clinical human use, and all handling should comply with standard research safety practices. Temperature excursions — even short periods above −20°C — can cause partial degradation without any obvious sign; always maintain cold chain and work with cold-shipped material. Bacterial endotoxin contamination is the primary safety concern specific to research peptides — verify endotoxin testing is included in the batch-specific COA before any injectable research application. PubMed are the primary literature resources for CJC-1295 research; favour indexed journal publications over preprints over case reports or anecdotal evidence.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
